Clinical Trial Update: Bupropion SR for Treating Smokeless Tobacco Use [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sustained-release bupropion for treating smokeless tobacco use has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Bupropion-SR (bupropion)

Snippet

Sponsor: Mayo Clinic | Conditions: Smokeless Tobacco | Phase 3 | Status: COMPLETED